{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:38:51Z","timestamp":1793723931592,"version":"4.6.1"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T00:00:00Z","timestamp":1708473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T00:00:00Z","timestamp":1708473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"DOI":"10.1007\/s10741-024-10393-y","type":"journal-article","created":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T07:02:20Z","timestamp":1708498940000},"page":"729-737","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Kinin-kallikrein system: New perspectives in heart failure"],"prefix":"10.1007","volume":"29","author":[{"given":"Keivan","family":"Mohammadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davood","family":"Shafie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9896-6548","authenticated-orcid":false,"given":"Newsha","family":"Ghomashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0984-4141","authenticated-orcid":false,"given":"Ali","family":"Abdolizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2652-3788","authenticated-orcid":false,"given":"Majid","family":"Sadeghpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,21]]},"reference":[{"key":"10393_CR1","doi-asserted-by":"publisher","first-page":"234","DOI":"10.2174\/187152509789105444","volume":"7","author":"JW Bryant","year":"2009","unstructured":"Bryant JW, Shariat-Madar Z (2009) Human plasma kallikrein-kinin system: physiological and biochemical parameters. Cardiovasc Hematol Agents Med Chem 7:234\u2013250. https:\/\/doi.org\/10.2174\/187152509789105444","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"key":"10393_CR2","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1517\/13543784.12.5.759","volume":"12","author":"H Heitsch","year":"2003","unstructured":"Heitsch H (2003) The therapeutic potential of bradykinin B2 receptor agonists in the treatment of cardiovascular disease. Expert Opin Investig Drugs 12:759\u2013770. https:\/\/doi.org\/10.1517\/13543784.12.5.759","journal-title":"Expert Opin Investig Drugs"},{"key":"10393_CR3","doi-asserted-by":"publisher","first-page":"H2317","DOI":"10.1152\/ajpheart.00815.2004","volume":"288","author":"I Liesmaa","year":"2005","unstructured":"Liesmaa I, Kuoppala A, Shiota N et al (2005) Increased expression of bradykinin type-1 receptors in endothelium of intramyocardial coronary vessels in human failing hearts. Am J Physiol Heart Circ Physiol 288:H2317-2322. https:\/\/doi.org\/10.1152\/ajpheart.00815.2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10393_CR4","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1093\/cvr\/cvy038","volume":"114","author":"O Sorop","year":"2018","unstructured":"Sorop O, Heinonen I, van Kranenburg M et al (2018) Multiple common comorbidities produce left ventricular diastolic dysfunction associated with coronary microvascular dysfunction, oxidative stress, and myocardial stiffening. Cardiovasc Res 114:954\u2013964. https:\/\/doi.org\/10.1093\/cvr\/cvy038","journal-title":"Cardiovasc Res"},{"key":"10393_CR5","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.phymed.2018.03.036","volume":"42","author":"J Hu","year":"2018","unstructured":"Hu J, Cheng P, Huang G-Y et al (2018) Effects of Xin-Ji-Er-Kang on heart failure induced by myocardial infarction: role of inflammation, oxidative stress and endothelial dysfunction. Phytomedicine 42:245\u2013257. https:\/\/doi.org\/10.1016\/j.phymed.2018.03.036","journal-title":"Phytomedicine"},{"key":"10393_CR6","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3390\/ph13110347","volume":"13","author":"S Hamid","year":"2020","unstructured":"Hamid S, Rhaleb IA, Kassem KM, Rhaleb N-E (2020) Role of kinins in hypertension and heart failure. Pharmaceuticals (Basel) 13:347. https:\/\/doi.org\/10.3390\/ph13110347","journal-title":"Pharmaceuticals (Basel)"},{"key":"10393_CR7","doi-asserted-by":"publisher","first-page":"e10596","DOI":"10.34172\/npj.2023.10596","volume":"12","author":"A Hasanpour Dehkordi","year":"2023","unstructured":"Hasanpour Dehkordi A, Zare Dehabadi E, Rezaei MR et al (2023) Empowerment and self-efficacy in patients with chronic disease; a systematic review study. J Nephropharmacol 12:e10596. https:\/\/doi.org\/10.34172\/npj.2023.10596","journal-title":"J Nephropharmacol"},{"key":"10393_CR8","doi-asserted-by":"publisher","DOI":"10.2196\/13166","volume":"21","author":"X Jiang","year":"2019","unstructured":"Jiang X, Ming W-K, You JH (2019) The cost-effectiveness of digital health interventions on the management of cardiovascular diseases: systematic review. J Med Internet Res 21:e13166. https:\/\/doi.org\/10.2196\/13166","journal-title":"J Med Internet Res"},{"key":"10393_CR9","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1093\/eurjpc\/zwaa147","volume":"28","author":"NL Bragazzi","year":"2021","unstructured":"Bragazzi NL, Zhong W, Shu J et al (2021) Burden of heart failure and underlying causes in 195 countries and territories from 1990 to 2017. Eur J Prev Cardiol 28:1682\u20131690. https:\/\/doi.org\/10.1093\/eurjpc\/zwaa147","journal-title":"Eur J Prev Cardiol"},{"key":"10393_CR10","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","volume":"62","author":"CW Yancy","year":"2013","unstructured":"Yancy CW, Jessup M, Bozkurt B et al (2013) 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 62:e147-239. https:\/\/doi.org\/10.1016\/j.jacc.2013.05.019","journal-title":"J Am Coll Cardiol"},{"key":"10393_CR11","volume-title":"StatPearls","author":"S Hajouli","year":"2023","unstructured":"Hajouli S, Ludhwani D (2023) Heart failure and ejection fraction. StatPearls. StatPearls Publishing, Treasure Island (FL)"},{"key":"10393_CR12","unstructured":"National Clinical Guideline Centre (UK) (2010) Chronic Heart Failure: National Clinical Guideline for Diagnosis and Management in Primary and Secondary Care: Partial Update. Royal College of Physicians (UK), London.\u00a0PMID: 22741186"},{"key":"10393_CR13","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/nrcardio.2016.25","volume":"13","author":"B Ziaeian","year":"2016","unstructured":"Ziaeian B, Fonarow GC (2016) Epidemiology and aetiology of heart failure. Nat Rev Cardiol 13:368\u2013378. https:\/\/doi.org\/10.1038\/nrcardio.2016.25","journal-title":"Nat Rev Cardiol"},{"key":"10393_CR14","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1093\/cvr\/cvz035","volume":"115","author":"WC Meijers","year":"2019","unstructured":"Meijers WC, de Boer RA (2019) Common risk factors for heart failure and cancer. Cardiovasc Res 115:844\u2013853. https:\/\/doi.org\/10.1093\/cvr\/cvz035","journal-title":"Cardiovasc Res"},{"key":"10393_CR15","volume-title":"Cardiovascular physiology","author":"DE Mohrman","year":"2018","unstructured":"Mohrman DE, Heller LJ (2018) Overview of the cardiovascular system. Cardiovascular physiology, 9th edn. McGraw-Hill Education","edition":"9"},{"key":"10393_CR16","volume-title":"StatPearls","author":"P LaCombe","year":"2023","unstructured":"LaCombe P, Jose A, Basit H, Lappin SL (2023) Physiology, starling relationships. StatPearls. StatPearls Publishing, Treasure Island (FL)"},{"key":"10393_CR17","doi-asserted-by":"publisher","first-page":"e523","DOI":"10.1161\/CIRCULATIONAHA.108.190748","volume":"118","author":"RO Bonow","year":"2008","unstructured":"Bonow RO, Carabello BA, Chatterjee K et al (2008) 2008 Focused update incorporated into the ACC\/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 118:e523-661. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.190748","journal-title":"Circulation"},{"key":"10393_CR18","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s10741-016-9536-9","volume":"21","author":"A Piek","year":"2016","unstructured":"Piek A, de Boer RA, Sillj\u00e9 HHW (2016) The fibrosis-cell death axis in heart failure. Heart Fail Rev 21:199\u2013211. https:\/\/doi.org\/10.1007\/s10741-016-9536-9","journal-title":"Heart Fail Rev"},{"key":"10393_CR19","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.24634","volume":"6","author":"L Alamo","year":"2017","unstructured":"Alamo L, Ware JS, Pinto A et al (2017) Effects of myosin variants on interacting-heads motif explain distinct hypertrophic and dilated cardiomyopathy phenotypes. Elife 6:e24634. https:\/\/doi.org\/10.7554\/eLife.24634","journal-title":"Elife"},{"key":"10393_CR20","doi-asserted-by":"publisher","first-page":"62","DOI":"10.5935\/abc.20160005","volume":"106","author":"PS Azevedo","year":"2016","unstructured":"Azevedo PS, Polegato BF, Minicucci MF et al (2016) Cardiac remodeling: concepts, clinical impact, pathophysiological mechanisms and pharmacologic treatment. Arq Bras Cardiol 106:62\u201369. https:\/\/doi.org\/10.5935\/abc.20160005","journal-title":"Arq Bras Cardiol"},{"key":"10393_CR21","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1161\/CIRCULATIONAHA.110.942268","volume":"122","author":"I Kehat","year":"2010","unstructured":"Kehat I, Molkentin JD (2010) Molecular pathways underlying cardiac remodeling during pathophysiological stimulation. Circulation 122:2727\u20132735. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.942268","journal-title":"Circulation"},{"key":"10393_CR22","doi-asserted-by":"publisher","first-page":"G950","DOI":"10.1152\/ajpgi.00132.2011","volume":"301","author":"TN Wight","year":"2011","unstructured":"Wight TN, Potter-Perigo S (2011) The extracellular matrix: an active or passive player in fibrosis? Am J Physiol Gastrointest Liver Physiol 301:G950\u2013G955. https:\/\/doi.org\/10.1152\/ajpgi.00132.2011","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10393_CR23","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00018-013-1349-6","volume":"71","author":"P Kong","year":"2014","unstructured":"Kong P, Christia P, Frangogiannis NG (2014) The pathogenesis of cardiac fibrosis. Cell Mol Life Sci 71:549\u2013574. https:\/\/doi.org\/10.1007\/s00018-013-1349-6","journal-title":"Cell Mol Life Sci"},{"key":"10393_CR24","doi-asserted-by":"publisher","first-page":"13027","DOI":"10.1073\/pnas.0805038105","volume":"105","author":"E van Rooij","year":"2008","unstructured":"van Rooij E, Sutherland LB, Thatcher JE et al (2008) Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci USA 105:13027\u201313032. https:\/\/doi.org\/10.1073\/pnas.0805038105","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10393_CR25","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/cphy.c140055","volume":"6","author":"E Tanai","year":"2015","unstructured":"Tanai E, Frantz S (2015) Pathophysiology of heart failure Compr Physiol 6:187\u2013214. https:\/\/doi.org\/10.1002\/cphy.c140055","journal-title":"Pathophysiology of heart failure Compr Physiol"},{"key":"10393_CR26","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/nrcardio.2016.163","volume":"14","author":"J Hartupee","year":"2017","unstructured":"Hartupee J, Mann DL (2017) Neurohormonal activation in heart failure with reduced ejection fraction. Nat Rev Cardiol 14:30\u201338. https:\/\/doi.org\/10.1038\/nrcardio.2016.163","journal-title":"Nat Rev Cardiol"},{"key":"10393_CR27","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1161\/CIRCRESAHA.113.300308","volume":"113","author":"A Lymperopoulos","year":"2013","unstructured":"Lymperopoulos A, Rengo G, Koch WJ (2013) Adrenergic nervous system in heart failure: pathophysiology and therapy. Circ Res 113:739\u2013753. https:\/\/doi.org\/10.1161\/CIRCRESAHA.113.300308","journal-title":"Circ Res"},{"key":"10393_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113238","volume":"152","author":"D Rotariu","year":"2022","unstructured":"Rotariu D, Babes EE, Tit DM et al (2022) Oxidative stress - complex pathological issues concerning the hallmark of cardiovascular and metabolic disorders. Biomed Pharmacother 152:113238. https:\/\/doi.org\/10.1016\/j.biopha.2022.113238","journal-title":"Biomed Pharmacother"},{"key":"10393_CR29","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1152\/physiol.00024.2007","volume":"22","author":"F Schweda","year":"2007","unstructured":"Schweda F, Friis U, Wagner C et al (2007) Renin release. Physiology 22:310\u2013319. https:\/\/doi.org\/10.1152\/physiol.00024.2007","journal-title":"Physiology"},{"key":"10393_CR30","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1172\/JCI0215490","volume":"109","author":"AH Schmaier","year":"2002","unstructured":"Schmaier AH (2002) The plasma kallikrein-kinin system counterbalances the renin-angiotensin system. J Clin Invest 109:1007\u20131009. https:\/\/doi.org\/10.1172\/JCI0215490","journal-title":"J Clin Invest"},{"key":"10393_CR31","volume-title":"StatPearls","author":"JH Fountain","year":"2023","unstructured":"Fountain JH, Kaur J, Lappin SL (2023) Physiology, renin angiotensin system. StatPearls. StatPearls Publishing, Treasure Island (FL)"},{"key":"10393_CR32","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/S0008-6363(00)00044-4","volume":"46","author":"J Schnee","year":"2000","unstructured":"Schnee J (2000) Angiotensin II, adhesion, and cardiac fibrosis. Cardiovasc Res 46:264\u2013268. https:\/\/doi.org\/10.1016\/S0008-6363(00)00044-4","journal-title":"Cardiovasc Res"},{"key":"10393_CR33","doi-asserted-by":"publisher","first-page":"252","DOI":"10.2174\/1573403X15666190306111812","volume":"15","author":"M Rodriguez","year":"2019","unstructured":"Rodriguez M, Hernandez M, Cheungpasitporn W et al (2019) Hyponatremia in heart failure: pathogenesis and management. CCR 15:252\u2013261. https:\/\/doi.org\/10.2174\/1573403X15666190306111812","journal-title":"CCR"},{"key":"10393_CR34","doi-asserted-by":"publisher","unstructured":"Potter LR, Yoder AR, Flora DR et al (2009) Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications. Handb Exp Pharmacol 341\u2013366. https:\/\/doi.org\/10.1007\/978-3-540-68964-5_15","DOI":"10.1007\/978-3-540-68964-5_15"},{"key":"10393_CR35","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1136\/hrt.2003.018325","volume":"92","author":"GA Wright","year":"2006","unstructured":"Wright GA, Struthers AD (2006) Natriuretic peptides as a prognostic marker and therapeutic target in heart failure. Heart 92:149\u2013151. https:\/\/doi.org\/10.1136\/hrt.2003.018325","journal-title":"Heart"},{"key":"10393_CR36","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1161\/CIRCRESAHA.116.308030","volume":"119","author":"SA Dick","year":"2016","unstructured":"Dick SA, Epelman S (2016) Chronic heart failure and inflammation: what do we really know? Circ Res 119:159\u2013176. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.308030","journal-title":"Circ Res"},{"key":"10393_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.103992","volume":"79","author":"GV Halade","year":"2022","unstructured":"Halade GV, Lee DH (2022) Inflammation and resolution signaling in cardiac repair and heart failure. EBioMedicine 79:103992. https:\/\/doi.org\/10.1016\/j.ebiom.2022.103992","journal-title":"EBioMedicine"},{"key":"10393_CR38","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s10557-020-07071-0","volume":"34","author":"A Hanna","year":"2020","unstructured":"Hanna A, Frangogiannis NG (2020) Inflammatory cytokines and chemokines as therapeutic targets in heart failure. Cardiovasc Drugs Ther 34:849\u2013863. https:\/\/doi.org\/10.1007\/s10557-020-07071-0","journal-title":"Cardiovasc Drugs Ther"},{"key":"10393_CR39","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1161\/01.CIR.0000165117.71483.0C","volume":"111","author":"M Li","year":"2005","unstructured":"Li M, Georgakopoulos D, Lu G et al (2005) p38 MAP kinase mediates inflammatory cytokine induction in cardiomyocytes and extracellular matrix remodeling in heart. Circulation 111:2494\u20132502. https:\/\/doi.org\/10.1161\/01.CIR.0000165117.71483.0C","journal-title":"Circulation"},{"key":"10393_CR40","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nrcardio.2014.28","volume":"11","author":"NG Frangogiannis","year":"2014","unstructured":"Frangogiannis NG (2014) The inflammatory response in myocardial injury, repair, and remodelling. Nat Rev Cardiol 11:255\u2013265. https:\/\/doi.org\/10.1038\/nrcardio.2014.28","journal-title":"Nat Rev Cardiol"},{"key":"10393_CR41","first-page":"153","volume":"15","author":"N Tran","year":"2022","unstructured":"Tran N, Garcia T, Aniqa M et al (2022) Endothelial nitric oxide synthase (eNOS) and the cardiovascular system: in physiology and in disease states. Am J Biomed Sci Res 15:153\u2013177","journal-title":"Am J Biomed Sci Res"},{"key":"10393_CR42","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3390\/genes4020101","volume":"4","author":"U Moens","year":"2013","unstructured":"Moens U, Kostenko S, Sveinbj\u00f8rnsson B (2013) The role of mitogen-activated protein kinase-activated protein kinases (MAPKAPKs) in inflammation. Genes (Basel) 4:101\u2013133. https:\/\/doi.org\/10.3390\/genes4020101","journal-title":"Genes (Basel)"},{"key":"10393_CR43","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10456-008-9099-z","volume":"11","author":"JA Nagy","year":"2008","unstructured":"Nagy JA, Benjamin L, Zeng H et al (2008) Vascular permeability, vascular hyperpermeability and angiogenesis. Angiogenesis 11:109\u2013119. https:\/\/doi.org\/10.1007\/s10456-008-9099-z","journal-title":"Angiogenesis"},{"key":"10393_CR44","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.114.002417","volume":"8","author":"B Lavin","year":"2015","unstructured":"Lavin B, Phinikaridou A, Lorrio S et al (2015) Monitoring vascular permeability and remodeling after endothelial injury in a murine model using a magnetic resonance albumin-binding contrast agent. Circ Cardiovasc Imaging 8:e002417. https:\/\/doi.org\/10.1161\/CIRCIMAGING.114.002417","journal-title":"Circ Cardiovasc Imaging"},{"key":"10393_CR45","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3109\/03009734.2015.1064501","volume":"120","author":"L Claesson-Welsh","year":"2015","unstructured":"Claesson-Welsh L (2015) Vascular permeability\u2014the essentials. Upsala J Med Sci 120:135\u2013143. https:\/\/doi.org\/10.3109\/03009734.2015.1064501","journal-title":"Upsala J Med Sci"},{"key":"10393_CR46","doi-asserted-by":"publisher","first-page":"4798","DOI":"10.3390\/ijms22094798","volume":"22","author":"G Battineni","year":"2021","unstructured":"Battineni G, Sagaro GG, Chintalapudi N et al (2021) Impact of obesity-induced inflammation on cardiovascular diseases (CVD). Int J Mol Sci 22:4798. https:\/\/doi.org\/10.3390\/ijms22094798","journal-title":"Int J Mol Sci"},{"key":"10393_CR47","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.ahj.2012.05.013","volume":"164","author":"DM Gopal","year":"2012","unstructured":"Gopal DM, Kalogeropoulos AP, Georgiopoulou VV et al (2012) Cigarette smoking exposure and heart failure risk in older adults: the Health, Aging, and Body Composition Study. Am Heart J 164:236\u2013242. https:\/\/doi.org\/10.1016\/j.ahj.2012.05.013","journal-title":"Am Heart J"},{"key":"10393_CR48","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1067\/mhj.2001.113078","volume":"141","author":"RJ Raymond","year":"2001","unstructured":"Raymond RJ, Dehmer GJ, Theoharides TC, Deliargyris EN (2001) Elevated interleukin-6 levels in patients with asymptomatic left ventricular systolic dysfunction. Am Heart J 141:435\u2013438. https:\/\/doi.org\/10.1067\/mhj.2001.113078","journal-title":"Am Heart J"},{"key":"10393_CR49","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.biopsycho.2018.01.015","volume":"133","author":"EM Paolucci","year":"2018","unstructured":"Paolucci EM, Loukov D, Bowdish DME, Heisz JJ (2018) Exercise reduces depression and inflammation but intensity matters. Biol Psychol 133:79\u201384. https:\/\/doi.org\/10.1016\/j.biopsycho.2018.01.015","journal-title":"Biol Psychol"},{"key":"10393_CR50","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s00059-019-4785-8","volume":"44","author":"C Riehle","year":"2019","unstructured":"Riehle C, Bauersachs J (2019) Key inflammatory mechanisms underlying heart failure. Herz 44:96\u2013106. https:\/\/doi.org\/10.1007\/s00059-019-4785-8","journal-title":"Herz"},{"key":"10393_CR51","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1160\/TH12-11-0840","volume":"110","author":"M Pathak","year":"2013","unstructured":"Pathak M, Wong SS, Dreveny I, Emsley J (2013) Structure of plasma and tissue kallikreins. Thromb Haemost 110:423\u2013433. https:\/\/doi.org\/10.1160\/TH12-11-0840","journal-title":"Thromb Haemost"},{"key":"10393_CR52","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0014-2999(01)01318-8","volume":"429","author":"R Couture","year":"2001","unstructured":"Couture R, Harrisson M, Vianna RM, Cloutier F (2001) Kinin receptors in pain and inflammation. Eur J Pharmacol 429:161\u2013176. https:\/\/doi.org\/10.1016\/S0014-2999(01)01318-8","journal-title":"Eur J Pharmacol"},{"key":"10393_CR53","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1254\/jphs.srj05001x","volume":"99","author":"ME Moreau","year":"2005","unstructured":"Moreau ME, Garbacki N, Molinaro G et al (2005) The kallikrein-kinin system: current and future pharmacological targets. J Pharmacol Sci 99:6\u201338. https:\/\/doi.org\/10.1254\/jphs.srj05001x","journal-title":"J Pharmacol Sci"},{"key":"10393_CR54","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/nrd1522","volume":"3","author":"F Marceau","year":"2004","unstructured":"Marceau F, Regoli D (2004) Bradykinin receptor ligands: therapeutic perspectives. Nat Rev Drug Discov 3:845\u2013852. https:\/\/doi.org\/10.1038\/nrd1522","journal-title":"Nat Rev Drug Discov"},{"key":"10393_CR55","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.cellsig.2018.08.006","volume":"51","author":"M Didiasova","year":"2018","unstructured":"Didiasova M, Wujak L, Schaefer L, Wygrecka M (2018) Factor XII in coagulation, inflammation and beyond. Cell Signal 51:257\u2013265. https:\/\/doi.org\/10.1016\/j.cellsig.2018.08.006","journal-title":"Cell Signal"},{"key":"10393_CR56","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1097\/MNH.0b013e32834d54b1","volume":"21","author":"Y Kayashima","year":"2012","unstructured":"Kayashima Y, Smithies O, Kakoki M (2012) The kallikrein-kinin system and oxidative stress. Curr Opin Nephrol Hypertens 21:92\u201396. https:\/\/doi.org\/10.1097\/MNH.0b013e32834d54b1","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10393_CR57","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/s0021-9150(02)00196-x","volume":"165","author":"F Zito","year":"2002","unstructured":"Zito F, Lowe GDO, Rumley A et al (2002) Association of the factor XII 46C>T polymorphism with risk of coronary heart disease (CHD) in the WOSCOPS study. Atherosclerosis 165:153\u2013158. https:\/\/doi.org\/10.1016\/s0021-9150(02)00196-x","journal-title":"Atherosclerosis"},{"key":"10393_CR58","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1161\/HYPERTENSIONAHA.109.144600","volume":"55","author":"EG Erd\u00f6s","year":"2010","unstructured":"Erd\u00f6s EG, Tan F, Skidgel RA (2010) Angiotensin I-converting enzyme inhibitors are allosteric enhancers of kinin B1 and B2 receptor function. Hypertension 55:214\u2013220. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.109.144600","journal-title":"Hypertension"},{"key":"10393_CR59","volume-title":"StatPearls","author":"RD Hill","year":"2023","unstructured":"Hill RD, Vaidya PN (2023) Angiotensin II receptor blockers (ARB). StatPearls. StatPearls Publishing, Treasure Island (FL)"},{"key":"10393_CR60","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1161\/01.hyp.0000036035.41122.99","volume":"40","author":"J Agata","year":"2002","unstructured":"Agata J, Chao L, Chao J (2002) Kallikrein gene delivery improves cardiac reserve and attenuates remodeling after myocardial infarction. Hypertension 40:653\u2013659. https:\/\/doi.org\/10.1161\/01.hyp.0000036035.41122.99","journal-title":"Hypertension"},{"key":"10393_CR61","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3389\/fphys.2018.00609","volume":"9","author":"A Sydykov","year":"2018","unstructured":"Sydykov A, Mamazhakypov A, Petrovic A et al (2018) Inflammatory mediators drive adverse right ventricular remodeling and dysfunction and serve as potential biomarkers. Front Physiol 9:609. https:\/\/doi.org\/10.3389\/fphys.2018.00609","journal-title":"Front Physiol"},{"key":"10393_CR62","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.regpep.2006.11.020","volume":"140","author":"Y-Y Yao","year":"2007","unstructured":"Yao Y-Y, Yin H, Shen B et al (2007) Tissue kallikrein infusion prevents cardiomyocyte apoptosis, inflammation and ventricular remodeling after myocardial infarction. Regul Pept 140:12\u201320. https:\/\/doi.org\/10.1016\/j.regpep.2006.11.020","journal-title":"Regul Pept"},{"key":"10393_CR63","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.ijbiomac.2019.08.195","volume":"140","author":"M Huang","year":"2019","unstructured":"Huang M, Du J, Wang Y et al (2019) Tissue kallikrein-related peptidase8 protects rat heart against acute ischemia reperfusion injury. Int J Biol Macromol 140:1126\u20131133. https:\/\/doi.org\/10.1016\/j.ijbiomac.2019.08.195","journal-title":"Int J Biol Macromol"},{"key":"10393_CR64","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1113\/expphysiol.2004.028464","volume":"90","author":"J Chao","year":"2005","unstructured":"Chao J, Chao L (2005) Kallikrein-kinin in stroke, cardiovascular and renal disease. Exp Physiol 90:291\u2013298. https:\/\/doi.org\/10.1113\/expphysiol.2004.028464","journal-title":"Exp Physiol"},{"key":"10393_CR65","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/2193-1801-3-221","volume":"3","author":"M Hara","year":"2014","unstructured":"Hara M, Kirita A, Kondo W et al (2014) LAP degradation product reflects plasma kallikrein-dependent TGF-\u03b2 activation in patients with hepatic fibrosis. Springerplus 3:221. https:\/\/doi.org\/10.1186\/2193-1801-3-221","journal-title":"Springerplus"},{"key":"10393_CR66","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/0955-2235(92)90017-C","volume":"4","author":"NA Noble","year":"1992","unstructured":"Noble NA, Harper JR, Border WA (1992) In vivo interactions of TGF-\u03b2 and extracellular matrix. Prog Growth Factor Res 4:369\u2013382. https:\/\/doi.org\/10.1016\/0955-2235(92)90017-C","journal-title":"Prog Growth Factor Res"},{"key":"10393_CR67","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1016\/S0195-668X(03)00441-X","volume":"24","author":"SS Dhamrait","year":"2003","unstructured":"Dhamrait SS, Payne JR, Li P et al (2003) Variation in bradykinin receptor genes increases the cardiovascular risk associated with hypertension. Eur Heart J 24:1672\u20131680. https:\/\/doi.org\/10.1016\/S0195-668X(03)00441-X","journal-title":"Eur Heart J"},{"key":"10393_CR68","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1161\/hc0502.102965","volume":"105","author":"ME Marin-Casta\u00f1o","year":"2002","unstructured":"Marin-Casta\u00f1o ME, Schanstra JP, Neau E et al (2002) Induction of functional bradykinin b(1)-receptors in normotensive rats and mice under chronic angiotensin-converting enzyme inhibitor treatment. Circulation 105:627\u2013632. https:\/\/doi.org\/10.1161\/hc0502.102965","journal-title":"Circulation"},{"key":"10393_CR69","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.phrs.2014.09.001","volume":"90","author":"AS More","year":"2014","unstructured":"More AS, Kim HM, Khang G et al (2014) Des-Arg9-bradykinin causes kinin B1 receptor mediated endothelium-independent contractions in endotoxin-treated porcine coronary arteries. Pharmacol Res 90:18\u201324. https:\/\/doi.org\/10.1016\/j.phrs.2014.09.001","journal-title":"Pharmacol Res"},{"key":"10393_CR70","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1365-2141.2005.05569.x","volume":"130","author":"M Cugno","year":"2005","unstructured":"Cugno M, Agostoni P, Mari D et al (2005) Impaired bradykinin response to ischaemia and exercise in patients with mild congestive heart failure during angiotensin-converting enzyme treatment. Relationships with endothelial function, coagulation and inflammation. Br J Haematol 130:113\u2013120. https:\/\/doi.org\/10.1111\/j.1365-2141.2005.05569.x","journal-title":"Br J Haematol"},{"key":"10393_CR71","doi-asserted-by":"publisher","first-page":"H784","DOI":"10.1152\/ajpheart.00793.2001","volume":"285","author":"C-C Wei","year":"2003","unstructured":"Wei C-C, Lucchesi PA, Tallaj J et al (2003) Cardiac interstitial bradykinin and mast cells modulate pattern of LV remodeling in volume overload in rats. Am J Physiol Heart Circ Physiol 285:H784-792. https:\/\/doi.org\/10.1152\/ajpheart.00793.2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10393_CR72","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.jacc.2006.06.083","volume":"49","author":"TD Ryan","year":"2007","unstructured":"Ryan TD, Rothstein EC, Aban I et al (2007) Left ventricular eccentric remodeling and matrix loss are mediated by bradykinin and precede cardiomyocyte elongation in rats with volume overload. J Am Coll Cardiol 49:811\u2013821. https:\/\/doi.org\/10.1016\/j.jacc.2006.06.083","journal-title":"J Am Coll Cardiol"},{"key":"10393_CR73","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0040110","volume":"7","author":"C-C Wei","year":"2012","unstructured":"Wei C-C, Chen Y, Powell LC et al (2012) Cardiac kallikrein-kinin system is upregulated in chronic volume overload and mediates an inflammatory induced collagen loss. PLoS ONE 7:e40110. https:\/\/doi.org\/10.1371\/journal.pone.0040110","journal-title":"PLoS ONE"},{"key":"10393_CR74","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.taap.2016.06.005","volume":"305","author":"X Lin","year":"2016","unstructured":"Lin X, Bernloehr C, Hildebrandt T et al (2016) Kinin B1 receptor blockade and ACE inhibition attenuate cardiac postinfarction remodeling and heart failure in rats. Toxicol Appl Pharmacol 305:153\u2013160. https:\/\/doi.org\/10.1016\/j.taap.2016.06.005","journal-title":"Toxicol Appl Pharmacol"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-024-10393-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-024-10393-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-024-10393-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T09:15:53Z","timestamp":1713777353000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-024-10393-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,21]]},"references-count":74,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["10393"],"URL":"https:\/\/doi.org\/10.1007\/s10741-024-10393-y","relation":{},"ISSN":["1573-7322"],"issn-type":[{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,21]]},"assertion":[{"value":"13 February 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}